Research & Reviews: A Journal of Bioinformatics

ISSN: 2393-8722

Editors Overview

rrjobi maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Emerging chemical, biological, and drug design concepts that are significant to pharmacology, ADMET, and drug delivery.

Abstract Submission Deadline : November 30, 2023

Manuscript Submission Deadline : December 25, 2023

Special Issue Description

To reduce investments and optimize lead compounds, drug discovery and development have increasingly relied on in vitro testing and silico predictions. Lipophilicity, solubility, and plasma stability are among the key parameters of absorption, distribution, metabolism, and excretion that can be determined in vitro. Such test systems aid in the evaluation of a compound’s pharmacological properties and serve as surrogates before in vivo testing and clinical trials. Conducting DMPK (Drug Metabolism and Pharmacokinetics) studies, also known as ADMET (Absorption, Distribution, Metabolism, Elimination, Toxicity) studies, is an important part of drug discovery and development. Computer-aided techniques are now used not only in discovering new lead compounds but also throughout the drug development process, where ADMET profiling and big data analytics add a new level of complexity to those systems.

Keywords

ADMET, Drug Design, Pharmacokinetics, Drug Metabolism, In silico predictions

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: